- Home
- OBIO
as 07-26-2024 4:00pm EST
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the global commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.
| Founded: | 2017 | Country: | United States |
| Employees: | N/A | City: | NEW HOPE |
| Market Cap: | 291.7M | IPO Year: | N/A |
| Target Price: | $16.33 | AVG Volume (30 days): | 247.1K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.48 | EPS Growth: | N/A |
| 52 Week Low/High: | $4.22 - $11.69 | Next Earning Date: | 08-08-2024 |
| Revenue: | $2,216,000 | Revenue Growth: | -42.16% |
| Revenue Growth (this year): | 17.9% | Revenue Growth (next year): | 10.51% |
Stock Insider Trading Activity of Orchestra BioMed Holdings Inc. (OBIO)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Hochman David P | OBIO | See Remarks | Jun 25 '24 | Buy | $6.95 | 1,000 | $6,950.00 | 333,502 | SEC Form 4 |
| Little William Reed | OBIO | See Remarks | May 30 '24 | Buy | $7.00 | 4,000 | $28,000.00 | 307,859 | SEC Form 4 |
| Hochman David P | OBIO | See Remarks | May 16 '24 | Buy | $5.15 | 3,000 | $15,450.00 | 332,502 | SEC Form 4 |
| Hochman David P | OBIO | See Remarks | May 16 '24 | Buy | $4.75 | 2,000 | $9,500.00 | 329,502 | SEC Form 4 |
Latest Orchestra BioMed Holdings Inc. News
OBIO Breaking Stock News: Dive into OBIO Ticker-Specific Updates for Smart Investing
Zacks
9 hours ago
Orchestra BioMed Holdings, Inc. (OBIO) Upgraded to Buy: Here's What You Should Know
Zacks
11 hours ago
Wall Street Analysts Believe Orchestra BioMed Holdings, Inc. (OBIO) Could Rally 102.61%: Here's is How to Trade
GlobeNewswire
4 days ago
Precision Neuroscience Expands Executive Team as Brain–Computer Interface Industry Rapidly Advances
Zacks
a month ago
Orchestra BioMed Holdings, Inc. (OBIO) Stock Jumps 7.3%: Will It Continue to Soar?
Simply Wall St.
a month ago
Orchestra BioMed Holdings, Inc.'s (NASDAQ:OBIO) largest shareholders are individual investors with 37% ownership, public companies own 16%
GOBankingRates
2 months ago
5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers
AFP
2 months ago
Bumrah delivers as India beat Pakistan in low-scoring thriller
AFP
2 months ago
Italy beat Bosnia in final Euros warm-up
Compare OBIO vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "OBIO Orchestra BioMed Holdings Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.